Care of the Pediatric Neuro-Oncology Population - On Demand

Friday, October 13, 2023, 8:30 AM - Wednesday, July 31, 2024, 11:00 PM

Neuro-oncology is a uniquely specialized field requiring providers to have advanced knowledge and understanding to optimize patient care. This on demand explores the implications of central nervous system cancers in the pediatric population along with nuances in treatment and prognosis for our youngest patients. Sessions include:

Advances in Pediatric Neuro-oncology

• Children Are Not Small Adults: An Overview of Pediatric Neuro-oncology — Cheryl Fischer, MSN, RN, CPNP-PC
• Advances in Pediatric Neuro Surgery — Mark Souweidane, MD
• Protons for Pediatric CNS Tumors — Suzanne Wolden, MD
• Developmental Therapeutics in Pediatric Neuro-Oncology: An Update from the Pediatric Brain Tumor Consortium — Ira Dunkel, MD

Novel Treatments in Pediatric Neuro-Oncology

• Molecular and Clinical Risk Directed Therapy for Medulloblastoma — Ira Dunkel, MD
• Pediatric Low Grade Gliomas: Diagnosis and Management in the Molecular Era — Matthias Karajannis, MD, MS
• Germ Cell Tumors in the Central Nervous System — Sameer Farouk Sait, MD

The Effects of Treatment in the Pediatric Patient

• Childhood Neurological Emergencies — Dorothea Dashiell, BS, MSN
• Neurocognitive Effects of Treatment — Stephen Sands, PsyD
• Physical and Endocrine Late Effects of Therapy — Elaine Pottenger, MS, RN, CPNP, PMHS

This on demand was recorded live on September 18, 2023, as part of the Essentials in Neuro-Oncology for the Advanced Practice Provider 2023 course, which is also available on demand as well.

Target Audience

This program is intended for Advanced Practice Providers, nurse practitioner students, physician assistant students, clinical nurse specialists, registered nurses, and physicians. We are pleased to offer complimentary registration to nursing students and registrants residing in low and lower-middle income countries.

On Demand Content and Access

To purchase this on demand program, select the Register tab above and complete all necessary information including payment. Once you have successfully registered, access to the course materials will be available under the Course Content tab.

This on demand is available for purchase through April 30, 2024. Once purchased, access to the content along with with claiming credit will be available through July 31, 2024.

1. Discuss the implications of a neuro-oncologic diagnosis in the pediatric population.

On Demand Fees

• Physicians (MDs, PhDs, and DOs) $70
• Advanced Practice Providers: $55
• Nursing and Other Healthcare Professionals: $40
• Residents, Fellows, and APP Students: $10
• Nursing Students and Registrants in Low-and Lower-Middle-Income Countries: Complimentary
• MSK Employees: Complimentary

Discounts and Complimentary Registration

• *We are pleased to offer complimentary registration to nursing students and registrants residing in low and lower-middle income countries as defined by The World Bank. If you qualify for complimentary registration, please submit a request here for a complimentary promotion code to use at registration. 
• A registration discount is available for MSK Alumni and MSK Cancer Alliance members to purchase this on demand. If you are a member of one of these groups, please submit your request here for this discount.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Recorded/Review Date: September 19, 2023  |  Original Release Date: October 13, 2023  |  Termination Date: July 31, 2024

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.